Cargando…

CD47 as a promising therapeutic target in oncology

CD47 is ubiquitously expressed on the surface of cells and plays a critical role in self-recognition. By interacting with SIRPα, TSP-1 and integrins, CD47 modulates cellular phagocytosis by macrophages, determines life span of individual erythrocytes, regulates activation of immune cells, and manipu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hai, Song, Shuangshuang, Ma, Junwei, Yan, Zhiyong, Xie, Hongwei, Feng, Ying, Che, Shusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446754/ https://www.ncbi.nlm.nih.gov/pubmed/36081498 http://dx.doi.org/10.3389/fimmu.2022.757480

Ejemplares similares

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
por: Liu, Liang, et al.
Publicado: (2017)

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
por: Zhang, Wenting, et al.
Publicado: (2020)

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020)

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
por: Yue, Chenran, et al.
Publicado: (2022)

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation
por: Okunuki, Yoko, et al.
Publicado: (2021)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
por: Schürch, Christian M., et al.
Publicado: (2019)

Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC
por: Nigro, Annunziata, et al.
Publicado: (2020)

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
por: Li, Yang, et al.
Publicado: (2022)

Dickkopf-1: A Promising Target for Cancer Immunotherapy
por: Chu, Hang Yin, et al.
Publicado: (2021)

Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
por: Yang, Yan, et al.
Publicado: (2021)

NETosis as an oncologic therapeutic target: a mini review
por: Jaboury, Sarah, et al.
Publicado: (2023)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
por: Chao, Mark P., et al.
Publicado: (2020)

CD47–SIRPα-targeted therapeutics: status and prospects
por: Maute, R., et al.
Publicado: (2022)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
por: Song, Xiaotian, et al.
Publicado: (2021)

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022)

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
por: Cao, Xu, et al.
Publicado: (2021)

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
por: Abd El-Fattah, Eslam E., et al.
Publicado: (2022)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
por: Rodríguez-Jiménez, Pedro, et al.
Publicado: (2019)

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
por: Yu, Lan, et al.
Publicado: (2021)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
por: Zhang, Nana, et al.
Publicado: (2023)

Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety
por: Gong, Sizhu, et al.
Publicado: (2023)

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke
por: Wei, Yan-hao, et al.
Publicado: (2023)

The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
por: Li, Yongmin, et al.
Publicado: (2023)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
por: Xi, Qing, et al.
Publicado: (2020)

The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes
por: Sharp, Robert C., et al.
Publicado: (2021)

SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation
por: Dehmani, Safa, et al.
Publicado: (2021)

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
por: Yoshida, Kazumichi, et al.
Publicado: (2015)

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
por: Sun, Jennifer, et al.
Publicado: (2021)

Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data
por: Son, Ji, et al.
Publicado: (2022)

Scald Injury-Induced T Cell Dysfunction Can Be Mitigated by Gr1(+) Cell Depletion and Blockage of CD47/CD172a Signaling
por: Beckmann, Nadine, et al.
Publicado: (2020)

Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases
por: Wang, Jinquan, et al.
Publicado: (2022)

Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
por: Hryhorowicz, Szymon, et al.
Publicado: (2021)

Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
por: Zhao, Mengmeng, et al.
Publicado: (2022)

Ferroptosis and musculoskeletal diseases: “Iron Maiden” cell death may be a promising therapeutic target
por: Zhang, Yili, et al.
Publicado: (2022)

Polymorphisms in the Human Inhibitory Signal-regulatory Protein α Do Not Affect Binding to Its Ligand CD47
por: Hatherley, Deborah, et al.
Publicado: (2014)

CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
por: Nath, Pulak Ranjan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jath6ikhkov2pqamqil6lff9v8